Case Report
Published on 28 Apr 2025
Early caplacizumab and obinutuzumab enable successful treatment of relapsing thrombotic thrombocytopenic purpura without therapeutic plasma exchange: a case report
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
- 2,694 views





